Name: Latest research reports of Torrent Pharmaceuticals Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Torrent Pharmaceuticals Ltd.
Rating: 3
Author: Motilal Oswal

Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE: 500420 | ISIN: INE685A01028 | Industry: Pharmaceuticals
| Expensive Star

4033.3000 93.00 (2.36%)

NSE Jan 19, 2026 09:07 AM

New 52W High in past week

Volume: 440

Torrent Pharmaceuticals Ltd.

23 Jul 2024

4033.30

2.36%

India/Germany businesses drive earnings

Neutral: Torrent Pharmaceuticals Ltd.

Target

Motilal Oswal

Torrent Pharma (TRP) delivered largely in-line 1QFY25. TRP posted robust 14.7% YoY growth in domestic formulation (DF) segment.

Torrent Pharmaceutic.. has an average target of 3978.00 from 7 brokers.